Skip to main content

Advertisement

SpringerLink
Log in

Erenumab in 159 high frequency and chronic migraine patients: real-life results from the Bologna Headache Center

  • BRIEF COMMUNICATION
  • Published:
Neurological Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Sacco S, Bendtsen L, Ashina M, Reuter U, Terwindt G, Mitsikostas D, Martelletti P (2019) European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention. J Headache Pain 20:6

    Article  Google Scholar 

  2. Barbanti P, Aurilia C, Egeo G, Fofi L (2019) Erenumab: from scientific evidence to clinical practice—the first Italian real-life data. Neurol Sci 40(1):177–179

    Article  Google Scholar 

  3. Ornello R, Casalena A, Frattale I et al (2020) Real-life data on the efficacy and safety of erenumab in the Abruzzo region, central Italy. J Headache Pain 21(1)

Download references

Author information

Authors and Affiliations

  1. Department of Biomedical and NeuroMotor Sciences (DiBiNeM), Bellaria Hospital, Alma Mater Studiorum - University of Bologna, Via Altura 3, 40139, Bologna, Italy

    Eleonora Matteo, Alessia Pascazio, Umberto Pensato, Matteo Benini, Gian Maria Asioli, Elena Merli, Calogero Calabrò, Pietro Cortelli & Giulia Pierangeli

  2. IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy

    Valentina Favoni, Pietro Cortelli, Giulia Pierangeli & Sabina Cevoli

Authors
  1. Eleonora Matteo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Valentina Favoni
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alessia Pascazio
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Umberto Pensato
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Matteo Benini
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Gian Maria Asioli
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Elena Merli
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Calogero Calabrò
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Pietro Cortelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Giulia Pierangeli
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Sabina Cevoli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sabina Cevoli.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants including the study.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Matteo, E., Favoni, V., Pascazio, A. et al. Erenumab in 159 high frequency and chronic migraine patients: real-life results from the Bologna Headache Center. Neurol Sci 41 (Suppl 2), 483–484 (2020). https://doi.org/10.1007/s10072-020-04667-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-020-04667-0

Search

Navigation